Unknown

Dataset Information

0

Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome.

ABSTRACT: Previously we showed that urine trefoil factor 3 (TFF3) levels were higher in females with irritable bowel syndrome (IBS) compared to non-IBS females. To assess if TFF3 is associated with symptoms and/or reflect alterations in gastrointestinal permeability and gut microbiota in an IBS population, we correlated stool and urine TFF3 levels with IBS symptoms, intestinal permeability, stool microbial diversity and relative abundance of predominant bacterial families and genera. We also tested the relationship of stool TFF3 to urine TFF3, and compared results based on hormone contraception use. Samples were obtained from 93 females meeting Rome III IBS criteria and completing 4-week symptom diaries. TFF3 levels were measured by ELISA. Permeability was assessed with the urine lactulose/mannitol (L/M) ratio. Stool microbiota was assessed using 16S rRNA. Stool TFF3, but not urine TFF3, was associated positively with diarrhoea and loose stool consistency. Higher stool TFF3 was also associated with lower L/M ratio and microbial diversity. Of the 20 most abundant bacterial families Mogibacteriaceae and Christensenellaceae were inversely related to stool TFF3, with only Christensenellaceae remaining significant after multiple comparison adjustment. There were no significant relationships between stool or urine TFF3 levels and other symptoms, nor between stool and urine levels. In premenopausal females, urine TFF3 levels were higher in those reporting hormone contraception. Collectively these results suggest that higher stool TFF3 levels are associated with IBS symptoms (loose/diarrhoeal stools), lower gut permeability, and altered stool bacteria composition (decreased diversity and decreased Christensenellaceae), which further suggests that TFF3 may be an important marker of host-bacteria interaction.

SUBMITTER: Heitkemper MM 

PROVIDER: S-EPMC6366941 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome.

Heitkemper M M MM   Cain K C KC   Shulman R J RJ   Burr R L RL   Ko C C   Hollister E B EB   Callen N N   Zia J J   Han C J CJ   Jarrett M E ME  

Beneficial microbes 20180410 3

Previously we showed that urine trefoil factor 3 (TFF3) levels were higher in females with irritable bowel syndrome (IBS) compared to non-IBS females. To assess if TFF3 is associated with symptoms and/or reflect alterations in gastrointestinal permeability and gut microbiota in an IBS population, we correlated stool and urine TFF3 levels with IBS symptoms, intestinal permeability, stool microbial diversity and relative abundance of predominant bacterial families and genera. We also tested the re  ...[more]

Similar Datasets

Unknown Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome.
| S-EPMC4102674 | biostudies-literature
Unknown MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.
| S-EPMC2891786 | biostudies-literature
Unknown Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity.
| S-EPMC5561162 | biostudies-literature
Unknown Diet and gut microbial associations in irritable bowel syndrome according to disease subtype.
| S-EPMC10549191 | biostudies-literature
Unknown The Associations of Single Nucleotide Polymorphisms with Risk and Symptoms of Irritable Bowel Syndrome.
| S-EPMC8878682 | biostudies-literature
Unknown Serpin-positive Bifidobacterium breve CNCM I-5644 improves intestinal permeability in two models of irritable bowel syndrome.
| S-EPMC9672316 | biostudies-literature
Unknown Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome.
| S-EPMC8915646 | biostudies-literature
Unknown Diarrhea-predominant Irritable Bowel Syndrome-like Symptoms in Patients With Quiescent Crohn's Disease: Comprehensive Analysis of Clinical Features and Intestinal Environment Including the Gut Microbiome, Organic Acids, and Intestinal Permeability.
| S-EPMC9837540 | biostudies-literature
Unknown Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome.
| S-EPMC10078221 | biostudies-literature
Unknown Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms.
| S-EPMC7300023 | biostudies-literature